If you liked this article you might like

Biotech Movers: OncoMed Tanks After Barrage of Bad News, Akorn Rises on Deal Talk
Biotech Premarket Movers: Innoviva, Akebia, Geron
Gilead Sciences' Next Challenge to Incyte's Myelofibrosis Drug Dominance
Geron (GERN) Stock Rises on $80 Million Janssen Licensing Deal